Allergan Aesthetics has secured European regulatory approval for Boey (trenibotulinumtoxinE), a rapid-onset, short-duration neuromodulator indicated for temporary improvement of frown lines in adults. The approval marks the first commercial availability of a botulinum toxin engineered for faster onset (claimed to begin within 24–48 hours) and shorter duration (~8 weeks) compared to standard formulations.
Injectables
Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neuromodulator
The rapid-acting toxin enters Europe; implications for glabellar-only positioning and unit economics remain to be tested.
1-YEAR MOVE
ABBV▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
Boey is the first rapid-onset, short-duration toxin approved in Europe, with onset claimed within 24–48 hours.
The mechanism—a recombinant botulinum toxin E—differs from the Type A toxins (onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA) that dominate current practice. Boey's positioning as glabellar-only and its shorter duration create a distinct market niche: patients seeking rapid results for events, or those trialing toxin for the first time. European adoption will test whether the premium pricing required to offset higher manufacturing complexity and shorter revenue cycles can compete against established Type A loyalty and rebate structures (Alle, Aspire programs). U.S. approval status remains unclear.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.